What can be termed a medical breakthrough, the researchers at the Tata Memorial Center of Mumbai have developed a new, affordable cancer treatment that can prevent cancer from recurring. The promising new cancer treatment is in the form of a ₹100 prooxidant tablet containing resveratrol and copper (R+Cu). This tablet targets a potential cause of cancer recurrence: cell fragments, cell-free chromatin particles (cfChPs), released by dying cancer cells that can trigger cancer in healthy cells. Containing resveratrol and copper, R+Cu generates oxygen radicals in the stomach that enter the bloodstream and destroy these cfChPs.
In pre-clinical trials on rats, R+Cu showed a 50 percent reduction in chemotherapy and radiation side effects. While early results suggest a 30 percent effectiveness in preventing cancer recurrence, human trials for prevention are still needed. This breakthrough offers hope for improved cancer treatment affordability and reduced patient burden. The tablet awaits approval from India’s food safety agency and could be available for human clinical trials by June-July 2024 if successful.
EXAMINING THE RESEARCH
This story is from the April 2024 edition of Healthcare Radius.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the April 2024 edition of Healthcare Radius.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
Are You Sleeping Enough, Doctor?
In this engaging conversation, we delve into the world of sleep with Dr Prashant Makhija, Consultant Neurologist, Wockhardt Hospital, Mumbai Central. Dr Prashant sheds light on the often overlooked aspect of healthcare–the sleep health of doctors. With a compassionate understanding of the challenges faced by the Indian doctors, he advocates for sleep equity, ensuring that our healthcare heroes are at their best for themselves and their patients.
Will India Eradicate Malaria By 2027?
India's ambitious malaria eradication goal faces a few hurdles despite progress made and the industry efforts.
Medikabazaar opens CDC in Kolkata
Medikabazaar, a B2B online healthcare platform, has inaugurated a new Central Distribution Center CDC) in Kolkata.
Alcon unveils Clareon IOLs in India
Global eye care player Alcon launches Clareon family of intraocular lenses IOLs) in India.
USV opens plant in Himachal Pradesh
To manufacture cardiology targeted medicine products at the new plant.
A RAY OF HOPE FOR HEART PATIENTS
Faced with severe heart failure, an 84-year-old gets a fresh lease of life due to Impella, a tiny device. Learn how Impella is changing patient lives in India.
R+CU'S CANCER TREATMENT PROMISE: HOPE OR HYPE?
Tata Memorial Center’s proposed cancer pill claims to tackle recurrence, but human trials are needed for confirmation, says the author.
BRIDGING THE KIDNEY TRANSPLANTS GAP
Explore the current landscape, including breakthroughs, access barriers, and promising future directions for kidney transplantation in modern India.
Wockhardt runs women empowerment campaign
Wockhardt Hospitals concludes International Women’s Day 2024 celebrations with “I am Fearless” campaign promoting women empowerment.
Feminine hygiene and cervical cancer awareness drive unveiled
CARE Hospitals launches Tejaswini, a CSR initiative focusing on feminine hygiene and cervical cancer awareness for girls in Hyderabad
